Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1994 Dec;113(4):1237–1242. doi: 10.1111/j.1476-5381.1994.tb17130.x

Differences in sensitivity to the specific protein kinase C inhibitor Ro31-8220 between small and large bronchioles of the rat.

L C Chopra 1, C H Twort 1, J P Ward 1
PMCID: PMC1510491  PMID: 7889278

Abstract

1. The involvement of protein kinase C (PKC) in constriction of small bronchioles has never been investigated. In this study we have examined the effects of the specific PKC inhibitors Ro31-8220 and Ro31-7549 and the non-specific inhibitor H7 on carbachol-, 5-hydroxytryptamine (5-HT)- and 4 beta-phorbol dibutyrate (4 beta-PDBu)-induced contractions in large and small bronchioles. 2. The study was performed on isolated bronchioles of the rat with internal diameters of 574 microns +/- 11 (small, n = 128), and 1475 microns +/- 32 (large, n = 93), using a Mulvaney-Halpen small vessel myograph. 3. In these preparations 4 beta-PDBu had no effect if added on its own. However, after precontracting with 30 mM K+, 0.5 microM 4 beta-PDBu caused a contractile response of 110.4 +/- 7.0% TK (TK = maximum response to 75 mM K+ in small and 69.3 +/- 6.5% TK in large bronchioles. Ro31-8220, Ro31-7549 and H7 all showed concentration-dependent inhibition of this response. 4. In small bronchioles 10 microM Ro31-8220 shifted both the carbachol and 5-HT concentration-response curves to the right, and reduced the maximum response. In contrast, 10 microM Ro31-8220 had no significant effect on the EC50 to carbachol of larger bronchioles, although the maximum response was reduced, and had no significant effect on the 5-HT concentration-response curve. 200 microM H7 shifted the carbachol concentration--response curve to the right as well as reducing the maximal response in both small and large bronchioles.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
1237

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrea J. E., Walsh M. P. Protein kinase C of smooth muscle. Hypertension. 1992 Nov;20(5):585–595. doi: 10.1161/01.hyp.20.5.585. [DOI] [PubMed] [Google Scholar]
  2. Berridge M. J., Irvine R. F. Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature. 1984 Nov 22;312(5992):315–321. doi: 10.1038/312315a0. [DOI] [PubMed] [Google Scholar]
  3. Bourreau J. P., Abela A. P., Kwan C. Y., Daniel E. E. Acetylcholine Ca2+ stores refilling directly involves a dihydropyridine-sensitive channel in dog trachea. Am J Physiol. 1991 Sep;261(3 Pt 1):C497–C505. doi: 10.1152/ajpcell.1991.261.3.C497. [DOI] [PubMed] [Google Scholar]
  4. Bradshaw D., Hill C. H., Nixon J. S., Wilkinson S. E. Therapeutic potential of protein kinase C inhibitors. Agents Actions. 1993 Jan;38(1-2):135–147. doi: 10.1007/BF02027225. [DOI] [PubMed] [Google Scholar]
  5. Castagna M., Takai Y., Kaibuchi K., Sano K., Kikkawa U., Nishizuka Y. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem. 1982 Jul 10;257(13):7847–7851. [PubMed] [Google Scholar]
  6. Cortijo J., Sanz C. M., Villagrasa V., Morcillo E. J., Small R. C. The effects of phorbol 12,13-diacetate on responses of guinea-pig isolated trachea to methylxanthines, isoprenaline and ryanodine. Br J Pharmacol. 1994 Mar;111(3):769–776. doi: 10.1111/j.1476-5381.1994.tb14804.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Davis P. D., Elliott L. H., Harris W., Hill C. H., Hurst S. A., Keech E., Kumar M. K., Lawton G., Nixon J. S., Wilkinson S. E. Inhibitors of protein kinase C. 2. Substituted bisindolylmaleimides with improved potency and selectivity. J Med Chem. 1992 Mar 20;35(6):994–1001. doi: 10.1021/jm00084a004. [DOI] [PubMed] [Google Scholar]
  8. Davis P. D., Hill C. H., Keech E., Lawton G., Nixon J. S., Sedgwick A. D., Wadsworth J., Westmacott D., Wilkinson S. E. Potent selective inhibitors of protein kinase C. FEBS Lett. 1989 Dec 18;259(1):61–63. doi: 10.1016/0014-5793(89)81494-2. [DOI] [PubMed] [Google Scholar]
  9. Fujiwara T., Itoh T., Kuriyama H. Regional differences in the mechanical properties of rabbit airway smooth muscle. Br J Pharmacol. 1988 Jun;94(2):389–396. doi: 10.1111/j.1476-5381.1988.tb11541.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hori M., Sato K., Miyamoto S., Ozaki H., Karaki H. Different pathways of calcium sensitization activated by receptor agonists and phorbol esters in vascular smooth muscle. Br J Pharmacol. 1993 Dec;110(4):1527–1531. doi: 10.1111/j.1476-5381.1993.tb13996.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Leach R. M., Twort C. H., Cameron I. R., Ward J. P. A comparison of the pharmacological and mechanical properties in vitro of large and small pulmonary arteries of the rat. Clin Sci (Lond) 1992 Jan;82(1):55–62. doi: 10.1042/cs0820055. [DOI] [PubMed] [Google Scholar]
  12. Menkes H., Baraban J. M., Snyder S. H. Protein kinase C regulates smooth muscle tension in guinea-pig trachea and ileum. Eur J Pharmacol. 1986 Mar 11;122(1):19–27. doi: 10.1016/0014-2999(86)90153-6. [DOI] [PubMed] [Google Scholar]
  13. Morrison K. J., Vanhoutte P. M. Inhibition of airway smooth muscle tone by a phorbol ester in the guinea pig trachea: role of epithelium and receptor reserve of the contractile agent. J Pharmacol Exp Ther. 1991 Oct;259(1):198–204. [PubMed] [Google Scholar]
  14. Murray R. K., Kotlikoff M. I. Receptor-activated calcium influx in human airway smooth muscle cells. J Physiol. 1991 Apr;435:123–144. doi: 10.1113/jphysiol.1991.sp018501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Nishizuka Y. Studies and perspectives of protein kinase C. Science. 1986 Jul 18;233(4761):305–312. doi: 10.1126/science.3014651. [DOI] [PubMed] [Google Scholar]
  16. Nixon J. S., Bishop J., Bradshaw D., Davis P. D., Hill C. H., Elliott L. H., Kumar H., Lawton G., Lewis E. J., Mulqueen M. The design and biological properties of potent and selective inhibitors of protein kinase C. Biochem Soc Trans. 1992 May;20(2):419–425. doi: 10.1042/bst0200419. [DOI] [PubMed] [Google Scholar]
  17. Savineau J. P., Marthan R., Crevel H. Contraction of vascular smooth muscle induced by phorbol 12,13 dibutyrate in human and rat pulmonary arteries. Br J Pharmacol. 1991 Nov;104(3):639–644. doi: 10.1111/j.1476-5381.1991.tb12482.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Schramm C. M., Grunstein M. M. Assessment of signal transduction mechanisms regulating airway smooth muscle contractility. Am J Physiol. 1992 Feb;262(2 Pt 1):L119–L139. doi: 10.1152/ajplung.1992.262.2.L119. [DOI] [PubMed] [Google Scholar]
  19. Schramm C. M., Grunstein M. M. Mechanisms of protein kinase C regulation of airway contractility. J Appl Physiol (1985) 1989 Apr;66(4):1935–1941. doi: 10.1152/jappl.1989.66.4.1935. [DOI] [PubMed] [Google Scholar]
  20. Shimamoto Y., Shimamoto H., Kwan C. Y., Daniel E. E. Differential effects of putative protein kinase C inhibitors on contraction of rat aortic smooth muscle. Am J Physiol. 1993 Apr;264(4 Pt 2):H1300–H1306. doi: 10.1152/ajpheart.1993.264.4.H1300. [DOI] [PubMed] [Google Scholar]
  21. Souhrada M., Souhrada J. F. Inhibitory effect of staurosporine on protein kinase C stimulation of airway smooth muscle cells. Am Rev Respir Dis. 1993 Aug;148(2):425–430. doi: 10.1164/ajrccm/148.2.425. [DOI] [PubMed] [Google Scholar]
  22. Takuwa Y., Takuwa N., Rasmussen H. Carbachol induces a rapid and sustained hydrolysis of polyphosphoinositide in bovine tracheal smooth muscle measurements of the mass of polyphosphoinositides, 1,2-diacylglycerol, and phosphatidic acid. J Biol Chem. 1986 Nov 5;261(31):14670–14675. [PubMed] [Google Scholar]
  23. Wilkinson S. E., Parker P. J., Nixon J. S. Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem J. 1993 Sep 1;294(Pt 2):335–337. doi: 10.1042/bj2940335. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES